COMPANY
MyoGene Bio
Funding and NIH signals
- NIH award NIH awarded $498K (SBIR commercialization 5SB1AR084953-02, continuation, notice Jul 9, 2026); 2 NIH awards totaling $1.48M in the last 12 months. NIH RePORTER 5SB1AR084953-02 (Jul 9, 2026)
Evidence (2 events)
- Jul 9, 2026 · NIH RePORTER 5SB1AR084953-02
Organization: MYOGENE BIO, LLC; City/State: San Diego, CA; Project number: 5SB1AR084953-02; Activity code: SB1; Fiscal year: 2026; Award notice date: 2026-07-09; FY total cost (award amount): 498365; Administering IC: National Institute of Arthritis and Musculoskeletal and Skin Diseases; Project title: Advancing manufacturing and release testing of a gene editing therapy for Duchenne muscular dystrophy; Organization type: Domestic For-Profits - May 13, 2026 · NIH RePORTER 5R44NS141438-05
Organization: MYOGENE BIO, LLC; City/State: San Diego, CA; Project number: 5R44NS141438-05; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-05-13; FY total cost (award amount): 978397; Administering IC: National Institute of Neurological Disorders and Stroke; Project title: Further assessment of durability of a gene editing therapy for Duchenne muscular dystrophy; Organization type: Domestic For-Profits
- Jul 9, 2026 · NIH RePORTER 5SB1AR084953-02
Timeline
- Grant Government grant — SBIR: $498,365 (annual award, as published), announced Jul 9, 2026. Agency: NIH/NIAMS. Source: government award database. source ↗
- Grant Government grant — SBIR: $978,397 (annual award, as published), announced May 13, 2026. Agency: NIH/NINDS. Source: government award database. source ↗
- Grant Government grant — SBIR: $499,300 (annual award, as published), announced Aug 28, 2025. Agency: NIH/NIAMS. Source: government award database. source ↗
- Grant Government grant — NIH R21: $302,500 (annual award, as published), announced Aug 20, 2025. Agency: NIH/NICHD. Source: government award database. source ↗
- Grant Government grant — NIH R21: $201,250 (annual award, as published), announced Jul 29, 2025. Agency: NIH/NCATS. Source: government award database. source ↗
- Grant Government grant — SBIR: $1.32M (annual award, as published), announced May 12, 2025. Agency: NIH/NINDS. Source: government award database. source ↗
Funding
- Government grant — SBIR: $498,365 (annual award, as published), announced Jul 9, 2026. Agency: NIH/NIAMS. Source: government award database. source ↗
- Government grant — SBIR: $978,397 (annual award, as published), announced May 13, 2026. Agency: NIH/NINDS. Source: government award database. source ↗
- Government grant — SBIR: $499,300 (annual award, as published), announced Aug 28, 2025. Agency: NIH/NIAMS. Source: government award database. source ↗
- Government grant — NIH R21: $302,500 (annual award, as published), announced Aug 20, 2025. Agency: NIH/NICHD. Source: government award database. source ↗
- Government grant — NIH R21: $201,250 (annual award, as published), announced Jul 29, 2025. Agency: NIH/NCATS. Source: government award database. source ↗
- Government grant — SBIR: $1.32M (annual award, as published), announced May 12, 2025. Agency: NIH/NINDS. Source: government award database. source ↗
NIH awards 5
- NIH award 1R21TR005162-01 FY2024: $110,000 awarded for that fiscal year; activity R21 (OTHER_NIH); PI YOUNG, COURTNEY S; recipient as written: MYOGENE BIO, LLC, San Diego, CA. Durability of a gene editing therapy tha source ↗
- NIH award 5R44AR075469-03 FY2022: $499,207 awarded for that fiscal year; activity R44 (SBIR); PI YOUNG, COURTNEY S; recipient as written: MYOGENE BIO, LLC, San Diego, CA. Pre-clinical development of SPY-DYS45-55, a C source ↗
- NIH award 1R43AR078042-01 FY2020: $149,919 awarded for that fiscal year; activity R43 (SBIR); PI YOUNG, COURTNEY S; recipient as written: MYOGENE BIO, LLC, San Diego, CA. Comparison of single versus dual vector deliv source ↗
- NIH award 4R44AR075469-02 FY2020: $493,728 awarded for that fiscal year; activity R44 (SBIR); PI YOUNG, COURTNEY S; recipient as written: MYOGENE BIO, LLC, San Diego, CA. Pre-clinical development of SPY-DYS45-55, a C source ↗
- NIH award 1R44AR075469-01A1 FY2019: $195,296 awarded for that fiscal year; activity R44 (SBIR); PI YOUNG, COURTNEY S; recipient as written: MYOGENE BIO, LLC, San Diego, CA. Pre-clinical development of SPY-DYS45-55, a source ↗